In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice

Human Gene Therapy
S ConnellyM Kaleko

Abstract

Hemophilia A is caused by blood coagulation factor VIII (FVIII) deficiency and is an attractive target for gene therapy. However, features of FVIII physiology, such as the instability of the mRNA and protein, have provided obstacles to the design of a feasible strategy for the transfer and expression of the human FVIII gene in vivo. We have constructed a recombinant adenoviral vector, Av1ALH81, that contains the human FVIII cDNA from which the B-domain has been deleted (BDD FVIII) and extensively characterized this vector in vitro and in vivo. In vitro, HepG2, human hepatoma cells, transduced with Av1ALH81 secreted high levels of biologically active human BDD FVIII measured by the Coatest bioassay (> 2,400 mU per 10(6) cells per 24 hr). Administration of Av1ALH81 to mice, via tail vein, resulted in expression of human BDD FVIII in the mouse plasma at levels averaging 307 +/- 93 ng/ml 1 week post-injection, measured by a sensitive human FVIII-specific ELISA. Normal FVIII levels in humans are 100-200 ng/ml, and therapeutic levels are as low as 10 ng/ml. Purification of the human FVIII from the mouse plasma, and subsequent Coatest analysis, revealed that the human FVIII produced in the mice was biologically active. In addition, th...Continue Reading

References

Jan 1, 1992·Annual Review of Medicine·R J Kaufman
Aug 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J J TooleR J Kaufman
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·K S ZaretD L Weinstat
Jun 21, 1994·Proceedings of the National Academy of Sciences of the United States of America·J F EngelhardtJ M Wilson
Mar 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·M A KayA R Thompson
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y YangJ M Wilson
May 24, 1994·Proceedings of the National Academy of Sciences of the United States of America·K ZatloukalM L Birnstiel
Aug 1, 1993·Current Opinion in Genetics & Development·J E Wilson, P M Macdonald
Apr 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J Herz, R D Gerard

❮ Previous
Next ❯

Citations

Feb 24, 2001·The Journal of Gene Medicine·L GraveM Mehtali
Mar 28, 2001·The Journal of Gene Medicine·M K ChuahT VandenDriessche
Oct 1, 1995·Current Opinion in Biotechnology·J L BramsonJ Gauldie
Oct 30, 1998·Critical Reviews in Oncology/hematology·M K ChuahT VandenDriessche
Feb 15, 2002·British Journal of Haematology·K J Pasi
Apr 25, 2001·Clinical and Laboratory Haematology·G EmilienC Casimir
Jan 5, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·S Connelly, M Kaleko
Apr 25, 2000·Human Gene Therapy·R SarkarH H Kazazian
Jan 20, 1996·Human Gene Therapy·S ConnellyM Kaleko
Aug 10, 1997·Human Gene Therapy·J N LozierR A Morgan
Mar 7, 2002·Current Opinion in Pediatrics·Christopher E Walsh
Aug 13, 2002·Current Opinion in Hematology·Paul E Monahan, Gilbert C White
Sep 24, 2010·Journal of Biomedicine & Biotechnology·Sara Pérez-Luz, Javier Díaz-Nido
Jun 24, 1998·The Journal of Clinical Investigation·S R CaiK P Ponder
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·M BurtonL Couto
May 20, 1998·Proceedings of the National Academy of Sciences of the United States of America·G L Evans, R A Morgan
Jun 11, 2005·Journal of Thrombosis and Haemostasis : JTH·C Hough, D Lillicrap
May 13, 2006·Journal of Thrombosis and Haemostasis : JTH·F LangerJ L Francis
Oct 28, 2004·Seminars in Hematology·Jay Lozier
Aug 12, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·J L AndrewsS Connelly
Dec 3, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·S RoyM Kaleko
Mar 29, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·J L AndrewsS Connelly
Jan 12, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·P Seshidhar ReddySheila Connelly
Feb 7, 2001·Circulation Research·K A High
Aug 31, 2002·Journal of Dairy Science·W FanD E Kerr
Dec 23, 1999·The Journal of Biological Chemistry·E L SaenkoA G Sarafanov

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.